Prokidney (PROK) Non-Current Assets (2021 - 2026)
Prokidney (PROK) reported Non-Current Assets of $57.9 million for Q1 2026, up 24.75% year-over-year from $46.4 million in Q1 2025, and up 5.44% quarter-over-quarter from $54.9 million in Q4 2025.
Prokidney (PROK) Non-Current Assets (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Non-Current Assets data on file, last reported at $57.9 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $57.9 million, up 24.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $212.1 million (up 14.61% YoY), and the FY2025 annual result was $54.9 million, up 21.48% from the prior year.
- Non-Current Assets grew to $57.9 million in Q1 2026 per PROK's latest filing, from $54.9 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $250.4 million in Q2 2022 and troughed at $13.1 million in Q3 2022.
- A 5-year average of $64.5 million and a median of $46.4 million in 2023 frame the typical range for Non-Current Assets.
- On a YoY basis, Non-Current Assets climbed as much as 65845.09% in 2022 and fell as far as 94.77% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $13.3 million in 2022, then jumped by 249.52% to $46.4 million in 2023, then declined by 2.62% to $45.2 million in 2024, then grew by 21.48% to $54.9 million in 2025, then grew by 5.44% to $57.9 million in 2026.
- Business Quant data shows PROK's Non-Current Assets at $57.9 million in Q1 2026, $54.9 million in Q4 2025, and $51.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 57.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.88 Mn |
| Dec 31, 2025 | 54.90 Mn |
| Sep 30, 2025 | 51.62 Mn |
| Jun 30, 2025 | 47.69 Mn |
| Mar 31, 2025 | 46.40 Mn |
| Dec 31, 2024 | 45.19 Mn |
| Sep 30, 2024 | 44.57 Mn |
| Jun 30, 2024 | 48.90 Mn |
| Mar 31, 2024 | 47.61 Mn |
| Dec 31, 2023 | 46.41 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 17.79 Mn |
| Mar 31, 2023 | 15.01 Mn |
| Dec 31, 2022 | 13.28 Mn |
| Sep 30, 2022 | 13.07 Mn |
| Jun 30, 2022 | 250.37 Mn |
| Mar 31, 2022 | 250.16 Mn |
| Dec 31, 2021 | 13.03 Mn |
| Sep 30, 2021 | 250.00 Mn |
| Jun 30, 2021 | 379,666.00 |